FDA Clears T2 Biosystems’ Key Update in Sepsis Battle
T2 Biosystems has received FDA clearance to update its T2Bacteria Panel, expanding its coverage of sepsis-causing pathogens and potentially leading ...
- Latest
- Trending
T2 Biosystems has received FDA clearance to update its T2Bacteria Panel, expanding its coverage of sepsis-causing pathogens and potentially leading ...
Online retail platform Temu poses a competitive threat to Amazon with its aggressive marketing approach, highlighted by heavy investment in ...
Luxury shoemaker Tod's saw a 17.4% increase in shares after receiving an acquisition bid from L Catterton. The bid, supported ...
Evidence suggests that technology-facilitated abuse disproportionately affects women, with 23% of Australian adults admitting to engaging in this behavior. This ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.